A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas

NCT04917861 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

808

Enrollment

INDUSTRY

Sponsor class

Conditions

Zika Virus

Interventions

BIOLOGICAL: mRNA-1893
BIOLOGICAL: Placebo

Sponsor

ModernaTX, Inc.